Apotex Inc.

In News

Apotex Completes Previously Announced Strategic Transaction with Cumberland Pharmaceuticals - PR Newswire

PR Newswire - Jul 01, 2026

Apotex Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs

Revelio Labs - Jul 28, 2026

Apotex Shares Rally as Trading Begins Following Pricing of C$1.3 Billion IPO - WSJ

WSJ - Jun 10, 2026

Apotex Health seeks to raise up to C$1.2 billion, potentially reviving Toronto IPO market - Reuters

Reuters - Jun 01, 2026

Baker Donelson Represents Cumberland Pharmaceuticals in Strategic Transaction to Integrate Commercial Business with Apotex - Baker Donelson

Baker Donelson - Apr 24, 2026

Apotex reports $38M net loss in first quarter after going public in June - Yahoo! Finance Canada

Yahoo! Finance Canada - Aug 12, 2026

Apotex reports $38M net loss in first quarter after going public in June - Toronto Star

Toronto Star - Aug 12, 2026

Cumberland to sell drug portfolio to Apotex for $100m - Pharmaceutical Technology

Pharmaceutical Technology - Apr 24, 2026

Apotex launches Apo‑Semaglutide Injection™, a generic equivalent of Ozempic®, in Canada - PR Newswire

PR Newswire - May 14, 2026

DifGen Pharmaceuticals LLC, in Collaboration with Apotex Inc., Announces FDA Approval of Generic Nintedanib Soft Gel Capsules, 100 mg and 150mg Therapeutically Equivalent to Ofev® - Yahoo Finance

Yahoo Finance - Apr 09, 2026

Hims offers Apotex's generic semaglutide in Canada after Novo patent expiry - Reuters

Reuters - May 21, 2026

Apotex becomes the first Canadian‑based pharmaceutical company to receive Health Canada approval for a generic equivalent of Ozempic® - PR Newswire

PR Newswire - May 01, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment